SOD1 and type 2 diabetes mellitus: HPR+ patients in both T2DM and hypercholesterolemia (HC) have a lower activity of plasma extracellular SOD, and platelet response to collagen/epinephrine platelet function analyzer-100 (CEPI PFA-100) indicates that only SOD substantially predicted platelet reactivity.